PROJECT 001 ? GENOME MAINTENANCE RESEARCH PROGRAM PROJECT SUMMARY/ABSTRACT Members of the Genome Maintenance Research Program (GM) are basic science researchers integrated by the common goal of understanding processes affecting the integrity, expression and duplication of the genome. Research themes within GM include carcinogen metabolism, cell division cycle control, chromatin and epigenetics, DNA replication and repair, DNA damage responses and gene expression. Discovery science that elucidates basic mechanisms, cancer etiology, and opportunities for therapeutic intervention is at the heart of GM. Program leaders foster interactions among GM members and between the Vanderbilt-Ingram Cancer Center (VICC) Research Programs that propel basic discoveries from the bench to clinical practice. In addition, the Program aims to support new research initiatives, build the research infrastructure necessary for discovery, mentor and educate junior members and trainees, and create a dynamic and collaborative environment that advances science faster and further than would be possible as individual laboratories. GM members also participate in two NCI-funded Specialized Programs of Research Excellence (SPOREs) in Gastrointestinal and Breast cancers, and several NIH training grants. GM houses the intellectual resources to support over 75 clinical trials open to accrual at VICC that use drugs that target DNA. In short, GM acts as the organizing entity for all cancer-focused DNA research at Vanderbilt. The GM members' research links to, and has impact for all, of the major cancer types within the VICC catchment area. There are 23 program members from seven departments and two schools, with $9.1M in total peer-reviewed funding and NCI making up 39% ($3.5M). Out of 332 publications, 13% are intra-programmatic and 23% are inter-programmatic. Members also have 106 collaborative publications with investigators at other NCI- designated cancer centers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-25
Application #
10024644
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1998-09-01
Project End
2025-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Werfel, Thomas A; Wang, Shan; Jackson, Meredith A et al. (2018) Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival. Cancer Res 78:1845-1858

Showing the most recent 10 out of 2462 publications